Zamri obtained his BSc in Chemistry and MSc in pharmacology from the University of Malaya and later PhD in Clinical Pharmacology from the University of London (UK) in 2007. Soon after completed his doctorate degree, he joined the Department of pharmacology, University of Malaya as a senior lecturer and currently serves as a Professor in the Department of Pharmacology and also Head of Universiti Malaya Research Centre for Biopharmaceuticals and Advanced Therapeutics (UBAT). He was recently awarded a Fellow by the British Pharmacological Society (FBPhS). His scope of research includes bioavailability and pharmacokinetic studies in human and animal models, drug delivery systems such as PEG-PLGA nanoparticles for systemic drug delivery, and semi solid formulations for transdermal and topical preparation.  Apart from human clinical trials and preclinical studies in animals, his research also covers the development of humanized mice model for cancers and cell based therapy for cancers. His laboratory also provides services and research in adulterated pharmaceutical products, xenobiotic studies on certain chemicals such as endocrine disruptors in food products, human bodies, etc. using GCMS, HPLC, LCMSMS, etc. Apart from his research activities, he also actively provided consultation to local pharmaceutical companies to conduct testing on pharmaceutical formulations especially for bioequivalence studies, comparative dissolution, etc. His bioequivalence laboratory has conducted more than 40 bioequivalence studies for generic drug formulations and also conducted drug analysis in biological and pharmaceutical formulations.   

    Dr. Zaharah Hussin is a Professor in the Department of Educational Foundation and Humanities, Faculty of Education, Universiti  Malaya (UM) born in Kedah. Prior to that, she was a secondary school teacher, SLAB tutor, lecturer and senior lecturer at UM. She is also a person who is also entrusted with administrative duties at UM since she started working as a lecturer in 1997 until now, starting from as the coordinator of Teaching Training, Head of Department and was the Deputy Dean (Higher Degree) in her Faculty. Her academic expertise is in the field of teacher training and educational research especially Islamic Education, Curriculum, Values ​​and Akhlak Education, philosophy in education, content analysis, Delphi techniques in research, model development and qualitative research in general. Dr. Zaharah is also active in publishing articles in national and international journals, academic books and presentations in conferences and webinars. Her book published by UM publisher entitled Akhlak  Education: Curriculum Analysis and Design was awarded the National Book Award 2018 Education category by the National Book Development Foundation in conjunction with the Book Fair 2018. He has also contributed teachers, researchers and experts particularly in Islamic Education field locally and internationally.  

Dr. Lim Wei Kang is a medical lecturer in the Department of Paediatrics, Faculty of Medicine, Universiti Malaya, and a consultant general paediatrician and paediatric neurologist at Universiti Malaya Medical Centre and Universiti Malaya Specialist Centre. He graduated from Cardiff University in the United Kingdom and subsequently completed his postgraduate training in general paediatrics at Universiti Malaya. Dr. Lim pursued subspecialty training in paediatric neurology in Malaysia before undertaking a clinical fellowship in paediatric movement disorders and neuromodulation at the Hospital for Sick Children, Canada. His clinical and academic interests centre on paediatric movement disorders, with a particular focus on the use of deep brain stimulation (DBS) in complex paediatric neurological conditions such as dystonia and epilepsy. He played a key role in establishing Malaysia’s first paediatric deep brain stimulation service, contributing significantly to the development of advanced neuromodulation care for children in the region. Dr. Lim continues to be actively involved in clinical service, teaching, and research, with ongoing efforts to expand access to specialized neurological care for children.